17-AAG increases autophagic removal of mutant androgen receptor in spinal and bulbar muscular atrophy

Neurobiology of Disease

Volumn 41, Issue 1, 2011, Pages 83-95

  Rusmini, Paola ^a,b   Simonini, Francesca ^a,b   Crippa, Valeria ^a,b   Bolzoni, Elena ^a,b   Onesto, Elisa ^a,b   Cagnin, Monica ^a,b   Sau, Daniela ^a,b   Ferri, Nicola ^a   Poletti, Angelo ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; COPPER ZINC SUPEROXIDE DISMUTASE; MUTANT PROTEIN; PROTEASOME; TANESPIMYCIN; TAR DNA BINDING PROTEIN; TESTOSTERONE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ARTICLE; AUTOPHAGY; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; EMBRYO; ENZYME ACTIVITY; KENNEDY DISEASE; MOUSE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DEFECT; PROTEIN DEGRADATION; PROTEIN FOLDING;

ANIMALS; AUTOPHAGY; BENZOQUINONES; CELL LINE, TRANSFORMED; LACTAMS, MACROCYCLIC; MICE; MOTOR NEURONS; MUSCULAR ATROPHY, SPINAL; MUTATION; NEUROPROTECTIVE AGENTS; PROTEOSTASIS DEFICIENCIES; RECEPTORS, ANDROGEN; UP-REGULATION;

EID: 78349309239     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2010.08.023     Document Type: Article

References (52)

1. Adachi H., et al. Heat shock protein 70 chaperone overexpression ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model by reducing nuclear-localized mutant androgen receptor protein. J. Neurosci. 2003, 23:2203-2211.
2. Allen S., et al. Analysis of the cytosolic proteome in a cell culture model of familial amyotrophic lateral sclerosis reveals alterations to the proteasome, antioxidant defenses, and nitric oxide synthetic pathways. J. Biol. Chem. 2003, 278:6371-6383.
3. Ayala Y.M., et al. Structural determinants of the cellular localization and shuttling of TDP-43. J. Cell Sci. 2008, 121:3778-3785.
4. Bailey C.K., et al. Molecular chaperones enhance the degradation of expanded polyglutamine repeat androgen receptor in a cellular model of spinal and bulbar muscular atrophy. Hum. Mol. Genet. 2002, 11:515-523.
5. Bence N.F., et al. Impairment of the ubiquitin-proteasome system by protein aggregation. Science 2001, 292:1552-1555.
6. Brinkmann A.O. Molecular basis of androgen insensitivity. Mol. Cell. Endocrinol. 2001, 179:105-109.
7. Cashman N.R., et al. Neuroblastoma x spinal cord (NSC) hybrid cell lines resemble developing motor neurons. Devel Dyn. 1992, 194:209-221.
8. Chomczynski P., Sacchi N. Single step method of RNA isolation by acid guanidinium thyocyanate-phenol chloroform extraction. Anal. Biochem. 1987, 162:156-158.
9. Cummings C.J., et al. Over-expression of inducible HSP70 chaperone suppresses neuropathology and improves motor function in SCA1 mice. Hum. Mol. Genet. 2001, 10:1511-1518.
10. Fujikake N., et al. Heat shock transcription factor 1-activating compounds suppress polyglutamine-induced neurodegeneration through induction of multiple molecular chaperones. J. Biol. Chem. 2008, 283:26188-26197.
11. He C., Klionsky D.J. Regulation mechanisms and signaling pathways of autophagy. Annu. Rev. Genet. 2009, 43:67-93.
12. Holmberg C.I., et al. Inefficient degradation of truncated polyglutamine proteins by the proteasome. EMBO J. 2004, 23:4307-4318.
13. Jinwal U.K., et al. Chemical manipulation of hsp70 ATPase activity regulates tau stability. J. Neurosci. 2009, 29:12079-12088.
14. Katsuno M., et al. Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Neuron 2002, 35:843-854.
15. Katsuno M., et al. Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy. Nat. Med. 2003, 9:768-773.
16. Katsuno M., et al. Pharmacological induction of heat-shock proteins alleviates polyglutamine-mediated motor neuron disease. Proc. Natl Acad. Sci. USA 2005, 102:16801-16806.
17. Klionsky D.J., et al. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 2008, 4:151-175.
18. Kobayashi Y., Sobue G. Protective effect of chaperones on polyglutamine diseases. Brain Res. Bull. 2001, 56:165-168.
19. Kobayashi Y., et al. Chaperones Hsp70 and Hsp40 suppress aggregate formation and apoptosis in cultured neuronal cells expressing truncated androgen receptor protein with expanded polyglutamine tract. J. Biol. Chem. 2000, 275:8772-8778.
20. La Spada A.R., et al. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 1991, 352:77-79.
21. LaFevre-Bernt M.A., Ellerby L.M. Kennedy's disease: phosphorylation of the polyQ-expanded form of androgen receptor regulates its cleavage by caspase-3 and enhances cell death. J. Biol. Chem. 2003, 278:34918-34924.
22. Lagier-Tourenne C., Cleveland D.W. Rethinking ALS: the FUS about TDP-43. Cell 2009, 136:1001-1004.
23. Marron T.U., et al. Androgen-induced neurite outgrowth is mediated by neuritin in motor neurones. J. Neurochem. 2005, 92:10-20.
24. Montie H.L., Merry D.E. Autophagy and access: understanding the role of androgen receptor subcellular localization in SBMA. Autophagy 2009, 5:1194-1197.
25. Montie H.L., et al. Cytoplasmic retention of polyglutamine-expanded androgen receptor ameliorates disease via autophagy in a mouse model of spinal and bulbar muscular atrophy. Hum. Mol. Genet. 2009, 18:1937-1950.
26. Nonaka T., et al. Truncation and pathogenic mutations facilitate the formation of intracellular aggregates of TDP-43. Hum. Mol. Genet. 2009, 18:3353-3364.
27. Orr H.T., Zoghbi H.Y. Trinucleotide repeat disorders. Annu. Rev. Neurosci. 2007, 30:575-621.
28. Palazzolo I., et al. The role of the polyglutamine tract in androgen receptor. J. Steroid Biochem. Mol. Biol. 2008, 108:245-253.
29. Pandey U.B., et al. HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature 2007, 447:859-863.
30. Pennuto M., et al. Post-translational modifications of expanded polyglutamine proteins: impact on neurotoxicity. Hum. Mol. Genet. 2009, 18:R40-R47.
31. Piccioni F., et al. Polyglutamine tract expansion of the androgen receptor in a motoneuronal model of spinal and bulbar muscular atrophy. Brain Res. Bull. 2001, 56:215-220.
32. Piccioni F., et al. Androgen receptor with elongated polyglutamine tract forms aggregates that alter axonal trafficking and mitochondrial distribution in motor neuronal processes. FASEB J. 2002, 160:1418-1420.
33. Poletti A. The polyglutamine tract of androgen receptor: from functions to dysfunctions in motor neurons. Front. Neuroendocrinol. 2004, 25:1-26.
34. Poletti A., et al. Chicken progesterone receptor expressed in Saccharomyces cerevisiae is correctly phosphorylated at all four Ser-Pro phosphorylation sites. Biochemistry 1993, 32:9563-9569.
35. Poletti A., et al. 5alpha-reductase type 2 and androgen receptor expression in gonadotropin releasing hormone GT1-1 cells. J. Neuroendocrinol. 2001, 13:353-357.
36. Poletti A., et al. Reflections on the diseases linked to mutations of the androgen receptor. Endocr. 2005, 28:243-262.
37. Pozzi P., et al. Androgen 5-alpha-reductase type 2 is highly expressed and active in rat spinal cord motor neurones. J. Neuroendocrinol. 2003, 15:882-887.
38. Riedel M., et al. 17-AAG induces cytoplasmic alpha-synuclein aggregate clearance by induction of autophagy. PLoS ONE 2010, 5:e8753.
39. Rusmini P., et al. Aggregation and proteasome: the case of elongated polyglutamine aggregation in spinal and bulbar muscular atrophy. Neurobiol. Aging 2007, 28:1099-1111.
40. Rusmini P., et al. Proteasomal and autophagic degradative activities in spinal and bulbar muscular atrophy. Neurobiol. Dis. 2010, 40:361-369.
41. Sau D., et al. Mutation of SOD1 in ALS: a Gain of a Loss of Function. Hum. Mol. Genet. 2007, 16:1604-1618.
42. Simeoni S., et al. Motoneuronal cell death is not correlated with aggregate formation of androgen receptors containing an elongated polyglutamine tract. Hum. Mol. Genet. 2000, 9:133-144.
43. Stenoien D.L., et al. Polyglutamine-expanded androgen receptors form aggregates that sequester heat shock proteins, proteasome components and SRC-1, and are suppressed by the HDJ-2 chaperone. Hum. Mol. Genet. 1999, 8:731-741.
44. Stenoien D.L., et al. Intranuclear ataxin1 inclusions contain both fast- and slow-exchanging components. Nat. Cell Biol. 2002, 10:806-810.
45. Takeuchi H., et al. Mitochondrial localization of mutant superoxide dismutase 1 triggers caspase-dependent cell death in a cellular model of familial amyotrophic lateral sclerosis. J. Biol. Chem. 2002, 277:50966-50972.
46. Tokui K., et al. 17-DMAG ameliorates polyglutamine-mediated motor neuron degeneration through well-preserved proteasome function in an SBMA model mouse. Hum. Mol. Genet. 2009, 18:898-910.
47. Tortarolo M., et al. Expression of SOD1 G93A or wild-type SOD1 in primary cultures of astrocytes down-regulates the glutamate transporter GLT-1: lack of involvement of oxidative stress. J. Neurochem. 2004, 88:481-493.
48. Vismara G., et al. Androgens inhibit androgen receptor promoter activation in motor neurons. Neurobiol. Dis. 2009, 33:395-404.
49. Warrick J.M., et al. Suppression of polyglutamine-mediated neurodegeneration in drosophila by the molecular chaperone HSP70. Nat. Genet. 1999, 23:425-428.
50. Waza M., et al. 17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration. Nat. Med. 2005, 11:1088-1095.
51. Waza M., et al. Modulation of Hsp90 function in neurodegenerative disorders: a molecular-targeted therapy against disease-causing protein. J. Mol. Med. 2006, 84:635-646.
52. Weigel N.L., et al. Phosphorylation and progesterone receptor function. J. Steroid Biochem. Mol. Biol. 1995, 53:509-514.